KR860000345B1 - Process for preparing cephalosporin derivatives - Google Patents

Process for preparing cephalosporin derivatives Download PDF

Info

Publication number
KR860000345B1
KR860000345B1 KR1019830001329A KR830001329A KR860000345B1 KR 860000345 B1 KR860000345 B1 KR 860000345B1 KR 1019830001329 A KR1019830001329 A KR 1019830001329A KR 830001329 A KR830001329 A KR 830001329A KR 860000345 B1 KR860000345 B1 KR 860000345B1
Authority
KR
South Korea
Prior art keywords
general formula
methyl
grams
following general
oxo
Prior art date
Application number
KR1019830001329A
Other languages
Korean (ko)
Other versions
KR840004112A (en
Inventor
김승호
Original Assignee
김승호
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 김승호 filed Critical 김승호
Priority to KR1019830001329A priority Critical patent/KR860000345B1/en
Publication of KR840004112A publication Critical patent/KR840004112A/en
Application granted granted Critical
Publication of KR860000345B1 publication Critical patent/KR860000345B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

Cephalosporin derivative (I), used as an antibiotic agent, is prepared from cephalosporin(V) by reacting with a thio ester (IV), having formula R1-CO-S-R2, obtained from acyl chloride (II), having formula R1-CO-Cl, by reacting with thiol (III), having formula HS-R2, where: R1 = (2-amino-4-thiazolyl) [(Z)-methoxyimino! methyl gp.; R2 = 2,5-dihydro-6-hydroxy-2-methyl-5-oxo-1,2,4triazine-3-yl gp.; and M = H, Na, or a protective gp.

Description

세팔로스포린 유도체의 제조방법Method for preparing cephalosporin derivative

본 발명은 그람양성 및 그람음성균의 항생작용에 특히 유요한 다음 일반식(Ⅰ)의 세팔로스포린 유도체의 새로운 제조방법에 관한 것이다.The present invention relates to a novel process for preparing cephalosporin derivatives of general formula (I), which is particularly useful for gram-positive and gram-negative antibiotics.

Figure kpo00001
Figure kpo00001

상기 일반식에서,In the above formula,

R'은(2-아미노-4-티아졸일)[(Z)-메톡시이미노] 메틸기를 나타내며,R 'represents a (2-amino-4-thiazolyl) [(Z) -methoxyimino] methyl group,

R2는 2,5-디하이드로-6-하이드록시-2-메틸-5-옥소-1,2,4-트리아진-3-일기를 나타내며,R 2 represents a 2,5-dihydro-6-hydroxy-2-methyl-5-oxo-1,2,4-triazin-3-yl group,

M은 수소, 나트륨 또는 보호기를 나타낸다.M represents hydrogen, sodium or a protecting group.

본 발명의 방법은 공지된 일반적인 아실화 방법과는 다른 신규의 방법이다.The method of the present invention is a novel method different from the known general acylation method.

상기 일반식(Ⅰ)의 세팔로스포린 유도체는 이미 문헌에 보고되어 있다. [참조 : 독일연방공화국 공개 특허 제2,922,036호] 공지의 아실화 방법에서는 세팔로스포린을 3위치에서 타올과 미리 반응시킨후 아실화하기 때문에 수율면에서 바람직하지 못하므로 경제성이 낮다.Cephalosporin derivatives of the general formula (I) have already been reported in the literature. [Reference: German Patent Application Laid-Open Patent No. 2,922,036] In the known acylation method, cephalosporin is reacted with a towel in advance at the 3 position and then acylated, which is not preferable in terms of yield, and thus economical efficiency is low.

본 발명자는 이러한 공지 방법의 단점을 해소시키기 위해 연구를 거듭한 결과, 세팔로스포린 유도체를 경제적으로 제조할 수 있는 방법을 발견하게 되었다.As a result of repeated studies to solve the disadvantages of the known methods, the inventors have found a method for economically preparing cephalosporin derivatives.

본 발명의 새로운 제조 방법을 반응도식으로 기재하면 다음과 같다.The novel production method of the present invention is described in the following scheme.

Figure kpo00002
Figure kpo00002

Figure kpo00003
Figure kpo00003

상기 일반식에서, R1,R2및 M은 상기에서 정의된 바와 같다.Wherein R 1 , R 2 and M are as defined above.

본 발명의 새로운 제조 방법을 일반적으로 서술하면 상기 일반식(Ⅱ)의 아실클로라이드와 상기 일반식(Ⅲ)의 티올을 반응시켜 얻어진 일반식(Ⅳ)의 티오에스테르를 상기 일반식(Ⅴ)의 세팔로스포린과 반응시켜 상기 일반식(Ⅰ)의 최종 생성물을 얻는 것이다. 이 목적에 사용되는 용매로서는 에틸에테르, 테트라하이드로푸란, 디옥산, 아세톤, 메틸에틸케톤, 클로로포름, 메틸렌클로라이드, 트리클로로에탄, 에틸아세테이트, 부틸아세테이트, 디메틸포름아미드 등이 있으며, 반응을 저해하지 않는 것이면 여하한 용매라도 좋다.In general, a new production method of the present invention is described by adding the thioester of the general formula (IV) obtained by reacting the acyl chloride of the general formula (II) with the thiol of the general formula (III). Reaction with palosporin affords the final product of formula (I). Solvents used for this purpose include ethyl ether, tetrahydrofuran, dioxane, acetone, methyl ethyl ketone, chloroform, methylene chloride, trichloroethane, ethyl acetate, butyl acetate, dimethylformamide, and the like, which do not inhibit the reaction. Any solvent may be used.

반응은 통상적으로 냉각하거나 실온에서 수행하나, 가온하에 수행할 수도 있다. 즉 통상 -20℃ 내지 35℃ 사이에서 반응하며, 바람직하기로는 -5℃ 내지 +5℃이다. 반응시간은 반응온도, 반응에 사용하는 화합물, 용매등에 따라 다르지만 수십분 내지 수십시간 내에서 적당히 선택되는데, 통상적으로는 30분 내지 48시간이며, 바람직하기는 1시간내지 10시간이다.The reaction is usually cooled or carried out at room temperature, but may also be carried out under warming. That is, it usually reacts between -20 ° C and 35 ° C, preferably -5 ° C to + 5 ° C. Although the reaction time varies depending on the reaction temperature, the compound used in the reaction, the solvent, and the like, it is appropriately selected within several tens of minutes to several tens of hours, and usually 30 minutes to 48 hours, preferably 1 hour to 10 hours.

본 발명은 앞에서 언급한 바와 같은 세팔로스포린 유도체를 매우 간단하게 제조할 수 있는 신규의 방법으로서 다음의 실시예로 더욱 자세히 설명하는 바, 이들 실시예로써 본 발명의 범위를 제한 하려는 것은 아니다.The present invention is a novel method for producing the cephalosporin derivative as mentioned above in a very simple manner and will be described in more detail in the following examples, which are not intended to limit the scope of the present invention.

[실시예 1]Example 1

가) 200미리리터의 메틸렌클로라이드에 18그람의 2-(2-아미노-4-티아졸일)-2-[(Z)-메톡시이미노]아세틸클로라이드를 넣고 실온에서 교반한다.A) Add 18 grams of 2- (2-amino-4-thiazolyl) -2-[(Z) -methoxyimino] acetyl chloride to 200 ml of methylene chloride and stir at room temperature.

나) 150미리리터의 메틸렌클로라이드에 16그람의 2,5-디하이드로-6-하이드록시-2-메틸-3-머캡토-5-옥소-1,2,4-트리아진을 넣고 실온에서 2시간 교반후 가)의 용액을 2시간에 걸쳐 가한다음, 트리엘틸아민으로 pH 6.5 내지 pH 7.0으로 맞추고 5시간동안 20℃ 내지 25℃에서 교반한후 다시 pH 6.5 내지 pH 7.0으로 맞추고 분액깔대기를 사용하여 100미리리터의 증류수로 2회 세척한 다음 유기층은 분리한다.B) Add 16 grams of 2,5-dihydro-6-hydroxy-2-methyl-3-mercapto-5-oxo-1,2,4-triazine to 150 milliliters of methylene chloride for 2 hours at room temperature After stirring, the solution of a) was added over 2 hours, adjusted to pH 6.5 to pH 7.0 with trieltylamine, stirred at 20 ° C. to 25 ° C. for 5 hours, and then adjusted to pH 6.5 to pH 7.0 again using a separatory funnel. After washing twice with 100 ml of distilled water, the organic layer is separated.

다) 400미리리터의 증류수에 27그람의 7-아미노 세팔로스포린산 및 14그람의 탄산칼륨을 녹인후 200미리리터의 메틸렌클로라이드를 넣고 교반하면서 0℃ 내지 5℃에서 나)의 생성물을 1시간에 걸쳐 서서히 가하고 1시간 교반후 수층을 분리하여 400미리리터의 메틸렌 클로라이드를 가하고 교반하면서 1N 염산으로 pH 2.0으로 맞춘 다음 유기층을 분리하여 100미리리터의 증류수로 세척하고 다시 유기층을 분리하여 황산마그네슘으로 탈수하고 여과한 다음 감압 농축하여 남은 노란색 고체에 100미리리터의 아세톤을 넣어 완전히 녹이고 600미리리터의 이소프로판올을 넣으면 결정이 석출된다. 이 결정을 여과하고 200미리리터의 이소프로판올로 세척하여 40℃에서 일야건조하면 40그람의 결정이 얻어진다.C) Dissolve 27 grams of 7-amino cephalosporinic acid and 14 grams of potassium carbonate in 400 milliliters of distilled water, add 200 milliliters of methylene chloride, and stir the product at 0 ° C to 5 ° C over 1 hour. After slowly adding and stirring for 1 hour, the aqueous layer was separated, 400 ml of methylene chloride was added thereto, and the mixture was stirred, adjusted to pH 2.0 with 1N hydrochloric acid, the organic layer was separated, washed with 100 ml of distilled water, and the organic layer was separated. After concentration under reduced pressure, 100 ml of acetone is completely dissolved in the remaining yellow solid, and 600 ml of isopropanol is added to precipitate crystals. The crystals were filtered, washed with 200 milliliters of isopropanol and dried overnight at 40 ° C. to obtain 40 grams of crystals.

라) 270미리리터의 아세톤 70미리리터의 n-부탄올 및 10미리리터의 증류수의 혼합용매에 40그람의 다)에서 생성된 결정을 녹인후 10.5그람의 나트륨2-에틸헥사노에이트를 270미리리터의 n-부탄올에 녹인 용액을 가하고 1시간이상 교반하면 결정이 서서히 석출된다. 이 결정을 여과하고 100미리리터의 아세톤으로 세척한후 40℃에서 일야건조하여 32그람의 7-[2-(2-아미노-4-티아졸일)-2-[(Z)-메톡시이미노] 아세트아미도]-3-[[(2,5-디하이드로-6-하이드록시-2-메틸-5-옥소-1,2,4-트리아진-3-일)티오]메틸]-8-옥소-5-티아-1-아자바이싸이클로[4.2.0]옥텟-2-앤-2-키복실산디나트륨염 하이드레이트를 얻는다.D) Dissolve the crystals produced in 40 g of c) in a mixed solvent of 270 ml of acetone 70 ml of n-butanol and 10 ml of distilled water, and then dissolve 10.5 grams of sodium 2-ethylhexanoate in 270 ml of n-butanol. After adding the dissolved solution to the mixture and stirring for 1 hour or more, crystals gradually precipitate. The crystals were filtered off, washed with 100 ml of acetone and dried overnight at 40 ° C. to 32 grams of 7- [2- (2-amino-4-thiazolyl) -2-[(Z) -methoxyimino] acet. Amido] -3-[[(2,5-dihydro-6-hydroxy-2-methyl-5-oxo-1,2,4-triazin-3-yl) thio] methyl] -8-oxo Obtain 5-5-thia-1-azabicyclo [4.2.0] octet-2-&-2-kisan disodium salt hydrate.

[실시예 2]Example 2

가) 100미리리터의 에틸아세테이트에 9그람의 2-(2-아미노-4-티아졸일)-2-[(Z)-메톡시이미노] 아세틸클로라이드를 넣고 실온에서 교반한다.A) Add 9 grams of 2- (2-amino-4-thiazolyl) -2-[(Z) -methoxyimino] acetyl chloride to 100 ml of ethyl acetate and stir at room temperature.

나) 80미리리터의 에틸아세테이트에 8그람의 2,5-디하이드로-6-하이드록시-2-메틸-3-머캡토-5-옥소-1,2,4-트리아진을 넣고 실온에서 2시간 교반후 가)의 용액을 1시간에 걸쳐 가하고 트리에틸 아민으로 pH 6.5 내지 pH 7.0으로 맞춘다음 5시간동안 교반한후 다시 pH 6.5 내지 pH 7.0으로 맞추고 분액깔대기를 사용하여 80미리리터의 증류수로 2회 세척하고 유기층을 분리한다.B) 8 grams of 2,5-dihydro-6-hydroxy-2-methyl-3-mercapto-5-oxo-1,2,4-triazine was added to 80 ml of ethyl acetate for 2 hours at room temperature. After stirring, the solution of a) was added over 1 hour, adjusted to pH 6.5 to pH 7.0 with triethyl amine, stirred for 5 hours, then adjusted to pH 6.5 to pH 7.0, and twice with 80 ml of distilled water using a separatory funnel. Wash and separate organic layer.

다) 150미리리터의 증류수에 13.6그람의 7-아미노 세팔로스포린산 및 5.3그람의 탄산나트륨을 녹인다.C) Dissolve 13.6 grams of 7-amino cephalosporinic acid and 5.3 grams of sodium carbonate in 150 milliliters of distilled water.

150미리리터의 에틸아세테이트를 넣고 0℃ 내지 5℃를 유지시키면서 나)의 생성물을 1시간에 걸쳐 서서히 가한후 1시간 이상 교반하고 수층을 분리한다. 수층에 150미리리터의 에틸아세테이트를 가하고 교반하면서 1N 염산으로 pH 2.0으로 맞춘다음 유기층을 분리하여 80미리리터의 증류수로 2회 세척하고 다시 유기층을 분리하여 황산 마그네슘으로 탈수하여 여과한 다음 농축하여 노란색 고체 약 29그람을 얻는다. 이 교체를 100미리리터의 아세톤 및 10미리리터의 증류수에 녹인후 8.5그람의 나트륨 2-에틸헥사노에이트를 100미리리터의 아세톤에 녹인 용액을 가하고 씨딩한후 0℃ 내지 5℃를 유지시키면서 2시간이상 교반한다.150 ml of ethyl acetate was added and the product of b) was slowly added over 1 hour while maintaining 0 ° C to 5 ° C, followed by stirring for 1 hour or more, and the aqueous layer was separated. 150 ml of ethyl acetate was added to the aqueous layer and the mixture was stirred, adjusted to pH 2.0 with 1N hydrochloric acid, the organic layer was separated, washed twice with 80 ml of distilled water, the organic layer was separated, dehydrated with magnesium sulfate, filtered, and concentrated to a yellow solid. Get 29 grams This replacement is dissolved in 100 ml of acetone and 10 ml of distilled water, and a solution of 8.5 grams of sodium 2-ethylhexanoate in 100 ml of acetone is added and seeded, followed by stirring for 2 hours while maintaining 0 to 5 ° C. do.

결정형의 침전물을 여과하고 100미리리터의 아세톤으로 세척한 후 40℃에서 일야 건조하여 16그람의 7-[2-(2-아미노-4-티아졸일)2-[(Z)-메톡시아미노] 아세트 아미도]-3-[[(2,5-디하이드로-6-하드록시-2-메틸-5-옥소-1,2,4-트리아진-3-일)티오]메틸]-8-옥소-5-티아-1-아자바이싸이클로[4.2.0] 옥텟-2-엔-2-카복실산디나트륨염 하이드레이드를 얻는다.The crystalline precipitate was filtered off, washed with 100 ml of acetone and dried overnight at 40 ° C. to yield 16 grams of 7- [2- (2-amino-4-thiazolyl) 2-[(Z) -methoxyamino] acet. Amido] -3-[[(2,5-dihydro-6-hydroxy-2-methyl-5-oxo-1,2,4-triazin-3-yl) thio] methyl] -8-oxo Obtain 5-5-thia-1-azabicyclo [4.2.0] octet-2-ene-2-carboxylic acid disodium salt hydride.

Claims (1)

다음 일반식(Ⅱ)의 아실클로라이드와 다음 일반식(Ⅲ)의 티올을 반응시켜 얻어진 다음 일반식(Ⅳ)의 티오에스테르를 다음 일반식(Ⅴ)의 세팔로스포린과 반응기내 반응 시킴을 특징으로 하여 다음 일반식(Ⅰ)의 세팔로스 포린유도체를 제조하는 방법.The reaction of acyl chloride of the following general formula (II) with thiol of the following general formula (III) and the reaction of thioester of the following general formula (IV) with cephalosporin of the following general formula (V) in a reactor To prepare a cephalosporin derivative of the following general formula (I).
Figure kpo00004
Figure kpo00004
Figure kpo00005
Figure kpo00005
상기 일반식에서 R1은(2-아미노-4-티아졸일)[(Z)-메톡시이미노] 메틸기를 나타내며, R2는 2,5-디하이드로-6-하이드록시-2-메틸-5-옥소-1,2,4-트리아진-3-일기를 나타내며, M은 수소, 나트륨 또는 보호기를 나타낸다.In the general formula, R 1 represents (2-amino-4-thiazolyl) [(Z) -methoxyimino] methyl group, and R 2 represents 2,5-dihydro-6-hydroxy-2-methyl-5- Represents an oxo-1,2,4-triazin-3-yl group and M represents hydrogen, sodium or a protecting group.
KR1019830001329A 1983-03-31 1983-03-31 Process for preparing cephalosporin derivatives KR860000345B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019830001329A KR860000345B1 (en) 1983-03-31 1983-03-31 Process for preparing cephalosporin derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019830001329A KR860000345B1 (en) 1983-03-31 1983-03-31 Process for preparing cephalosporin derivatives

Publications (2)

Publication Number Publication Date
KR840004112A KR840004112A (en) 1984-10-06
KR860000345B1 true KR860000345B1 (en) 1986-04-12

Family

ID=19228584

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019830001329A KR860000345B1 (en) 1983-03-31 1983-03-31 Process for preparing cephalosporin derivatives

Country Status (1)

Country Link
KR (1) KR860000345B1 (en)

Also Published As

Publication number Publication date
KR840004112A (en) 1984-10-06

Similar Documents

Publication Publication Date Title
KR100442717B1 (en) Crystalline amine salt of cefdinir
JPH02311483A (en) Preparation of ceftriaxone
EP0333154B1 (en) Process for the preparation of cephem derivatives
US4608373A (en) Cephem compounds
US4003896A (en) Method of preparing a sparingly soluble complex of cephalexin
PL177317B1 (en) Novel complexes of beta-lactames and method of obtaining beta-lactames
EP0113568B1 (en) Intermediates for the preparation of ceftazidine, and process for their preparation
EP0272487A1 (en) Cephalosporin derivatives and their crystalline derivatives, process for the preparation of the same, intermediates for use in the synthesis of the same, pharmaceutical compositions comprising the same, and the use of the same for the manufacture of a medicament having valuable therapeutic and preventative properties
US5869649A (en) Process for producing cephalosporin antibiotics
KR860000345B1 (en) Process for preparing cephalosporin derivatives
JPS61122290A (en) Manufacture of cephalosporin derivative
HU213267B (en) Process for producing stereospecific cefepime-dihydrochloride-hydrate at ph 5-7,5
IE51358B1 (en) 1,2,4-triazinylthiomethyl-3-cephem sulfoxides,process for their preparation and pharmaceutical compositions containing them
US4959495A (en) Process for the preparation of intermediates used to produce aminothiazoloximino cephalosporins
HU192558B (en) Process for producing cristalline 7-/r/-amino-3-/1-piridinium-methyl/-ceph-3-eme-4-carboxilate derivatives
US3971780A (en) Thio-β-lactam cephalosporins
US4659812A (en) Cephalosporin intermediates
KR950010085B1 (en) New stable crystalline form of an intermediate product of cephalo sporine
EP0023045A1 (en) Imidazolecarboxylic acid derivatives of penicillins and cephalosporins
KR830001970B1 (en) Method for preparing cephalosporin derivative
KR840001378B1 (en) Process for preparing gephabsporaic acid derivatives
KR850001960B1 (en) Process for preparing cephalosporin derivatives
US5066799A (en) Intermediates for the preparation of aminothiazoloximino cephalosporins
KR960011779B1 (en) Novel process for preparing crystalline hydrate of cephalosporin
US4039537A (en) Thio-β-lactam cephalosporins

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application
J2X1 Appeal (before the patent court)

Free format text: APPEAL AGAINST DECISION TO DECLINE REFUSAL

Free format text: TRIAL NUMBER: 1985201000023; APPEAL AGAINST DECISION TO DECLINE REFUSAL

G160 Decision to publish patent application
O035 Opposition [patent]: request for opposition
O035 Opposition [patent]: request for opposition
E701 Decision to grant or registration of patent right
O073 Decision to grant registration after opposition [patent]: decision to grant registration
O132 Decision on opposition [patent]
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 19871230

Year of fee payment: 12

LAPS Lapse due to unpaid annual fee